Early Use of the NMDA Receptor Antagonist Ketamine in Refractory and Superrefractory Status Epilepticus
about
Treatment of drug-induced seizuresA Potential Role for Felbamate in TSC- and NF1-Related Epilepsy: A Case Report and Review of the Literature.SRR intronic variation inhibits expression of its neighbouring SMG6 gene and protects against temporal lobe epilepsy.Burden of illness for super-refractory status epilepticus patients.
P2860
Early Use of the NMDA Receptor Antagonist Ketamine in Refractory and Superrefractory Status Epilepticus
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Early Use of the NMDA Receptor ...... rrefractory Status Epilepticus
@ast
Early Use of the NMDA Receptor ...... rrefractory Status Epilepticus
@en
Early Use of the NMDA Receptor ...... rrefractory Status Epilepticus
@nl
type
label
Early Use of the NMDA Receptor ...... rrefractory Status Epilepticus
@ast
Early Use of the NMDA Receptor ...... rrefractory Status Epilepticus
@en
Early Use of the NMDA Receptor ...... rrefractory Status Epilepticus
@nl
prefLabel
Early Use of the NMDA Receptor ...... rrefractory Status Epilepticus
@ast
Early Use of the NMDA Receptor ...... rrefractory Status Epilepticus
@en
Early Use of the NMDA Receptor ...... rrefractory Status Epilepticus
@nl
P2860
P356
P1476
Early Use of the NMDA Receptor ...... rrefractory Status Epilepticus
@en
P2093
F. A. Zeiler
P2860
P304
P356
10.1155/2015/831260
P407
P577
2015-01-01T00:00:00Z